Zbigniew Hruby

481 total citations
32 papers, 282 citations indexed

About

Zbigniew Hruby is a scholar working on Nephrology, Infectious Diseases and Surgery. According to data from OpenAlex, Zbigniew Hruby has authored 32 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 5 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Zbigniew Hruby's work include Renal Diseases and Glomerulopathies (12 papers), Chronic Kidney Disease and Diabetes (6 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Zbigniew Hruby is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Chronic Kidney Disease and Diabetes (6 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Zbigniew Hruby collaborates with scholars based in Poland, Canada and Czechia. Zbigniew Hruby's co-authors include R P Lowry, Wojciech Witkiewicz, Andrzej Konieczny, Serge Jothy, Kinji Shirota, J Rabczyński, Wiesław Kopeć, Andrzej Steciwko, Jacek Bogucki and Małgorzata Zalewska and has published in prestigious journals such as Kidney International, Nephrology Dialysis Transplantation and Clinical & Experimental Immunology.

In The Last Decade

Zbigniew Hruby

29 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zbigniew Hruby Poland	9	112	62	56	50	40	32	282
Marie-Noëlle Peraldi France	9	154 1.4×	72 1.2×	106 1.9×	39 0.8×	50 1.3×	10	402
Amir Shabaka Spain	10	215 1.9×	76 1.2×	42 0.8×	50 1.0×	78 1.9×	37	418
Vasil Peev United States	7	155 1.4×	39 0.6×	41 0.7×	42 0.8×	36 0.9×	12	277
M. Motta Italy	11	105 0.9×	73 1.2×	47 0.8×	77 1.5×	63 1.6×	17	377
Daisuke Saga Japan	7	115 1.0×	71 1.1×	107 1.9×	43 0.9×	13 0.3×	9	429
Xiqiang Dang China	11	142 1.3×	132 2.1×	66 1.2×	28 0.6×	62 1.6×	58	380
Hidehisa Kitada Japan	13	66 0.6×	60 1.0×	28 0.5×	119 2.4×	38 0.9×	39	324
Cengiz Candan Türkiye	12	211 1.9×	90 1.5×	36 0.6×	52 1.0×	53 1.3×	29	390
Franziska Kraft Germany	5	102 0.9×	103 1.7×	184 3.3×	31 0.6×	51 1.3×	5	340
P. Gollapudi United States	7	112 1.0×	51 0.8×	125 2.2×	53 1.1×	29 0.7×	9	369

Countries citing papers authored by Zbigniew Hruby

Since Specialization

Citations

This map shows the geographic impact of Zbigniew Hruby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zbigniew Hruby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zbigniew Hruby more than expected).

Fields of papers citing papers by Zbigniew Hruby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zbigniew Hruby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zbigniew Hruby. The network helps show where Zbigniew Hruby may publish in the future.

Co-authorship network of co-authors of Zbigniew Hruby

This figure shows the co-authorship network connecting the top 25 collaborators of Zbigniew Hruby. A scholar is included among the top collaborators of Zbigniew Hruby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zbigniew Hruby. Zbigniew Hruby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Konieczny, Andrzej, et al.. (2023). The Artificial Neural Network as a Diagnostic Tool of the Risk of Clostridioides difficile Infection among Patients with Chronic Kidney Disease. Journal of Clinical Medicine. 12(14). 4751–4751. 1 indexed citations

Konieczny, Andrzej, et al.. (2020). Clostridioides difficile infection in patients with end stage renal disease. Is it preventable?. Przeglad Epidemiologiczny. 74(1). 11–21. 4 indexed citations

Konieczny, Andrzej, et al.. (2019). Clostridium difficile infection in patients with end stage renal disease. Is it preventable?. 4(2). 1 indexed citations

Konieczny, Andrzej, et al.. (2019). Glomerular podocytes in diabetic renal disease. Advances in Clinical and Experimental Medicine. 28(12). 1711–1715. 56 indexed citations

Konieczny, Andrzej, et al.. (2018). Risk factors of the Clostridium difficile infection in patients with chronic kidney disease. Advances in Clinical and Experimental Medicine. 27(8). 1081–1084. 6 indexed citations

Málek, Jiří, et al.. (2014). Nasal oxytocin as anxiolytic agent before stomatology treatment. European Journal of Anaesthesiology. 31. 146–146. 1 indexed citations

Hruby, Zbigniew, et al.. (2013). The clinicopathological determinants of native arteriovenous fistula failure in patients on maintenance hemodialysis.. PubMed. 22(4). 495–500. 5 indexed citations

Hruby, Zbigniew, et al.. (2008). Parenchymal injury in remnant-kidney model may be linked to apoptosis of renal cells mediated by nitric oxide. Journal of Nephrology. 21(5). 686–693. 5 indexed citations

Ryba‐Stanisławowska, Monika, et al.. (2006). [Fabry disease].. PubMed. 63(4). 218–9. 1 indexed citations

10.

Hruby, Zbigniew, et al.. (2003). Urinary excretion of growth factors/cytokines and progression of diabetic nephropathy with overt proteinuria. Advances in Clinical and Experimental Medicine. 12(6). 723–729.

11.

Hruby, Zbigniew, et al.. (1999). Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy. Research in Experimental Medicine. 199(5). 295–307. 6 indexed citations

12.

Hruby, Zbigniew, et al.. (1997). Cytotoxic effect of autocrine and macrophage-derived nitric oxide on cultured rat mesangial cells. Clinical & Experimental Immunology. 107(1). 76–82. 27 indexed citations

13.

Hruby, Zbigniew, et al.. (1997). <i>Helicobacter</i><i>pylori</i> in Kidney Allograft Recipients: High Prevalence of Colonization and Low Incidence of Active Inflammatory Lesions. Nephron. 75(1). 25–29. 25 indexed citations

14.

Hruby, Zbigniew, et al.. (1996). Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis. Nephrology Dialysis Transplantation. 11(1). 32–39. 8 indexed citations

15.

Hruby, Zbigniew, et al.. (1994). A case of severe anti-neutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis and asymptomatic gastric cancer. International Urology and Nephrology. 26(5). 579–586. 21 indexed citations

16.

Hruby, Zbigniew, et al.. (1992). The variety of clinical and histopathologic presentations of glomerulonephritis associated with latent syphilis. International Urology and Nephrology. 24(5). 541–547. 15 indexed citations

17.

Hruby, Zbigniew, Kinji Shirota, Serge Jothy, & R P Lowry. (1991). Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury. Kidney International. 40(1). 43–51. 48 indexed citations

18.

Hruby, Zbigniew, et al.. (1990). Effects of Tumor Necrosis Factor on Glomerular Mesangial and Epithelial Cells in Culture. The Nephron journals/Nephron journals. 56(4). 410–413. 10 indexed citations

19.

Hruby, Zbigniew, et al.. (1989). The effect of epsilon-aminocaproic acid (EACA) on experimental immune nephritis.. PubMed. 37(5-6). 629–39. 2 indexed citations

20.

Hruby, Zbigniew, et al.. (1985). Activity of circulating monocytes in patients with chronic glomerulonephritis. International Urology and Nephrology. 17(4). 379–387. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact